NEXGEL, Inc. (NXGL) Q1 2026 Earnings Call Transcript
NEXGEL, Inc. (NXGL) Q1 2026 Earnings Call Transcript
Seeking Alpha5/15/2026Neutral
NXGL
Nexgel IncNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$3.09M
P/E Ratio
—
EPS
$-0.74
Beta
0.75
52W High
$2.89
52W Low
$0.30
50-Day MA
$0.43
200-Day MA
$0.91
Dividend Yield
—
Profit Margin
-51.30%
Forward P/E
1.38
PEG Ratio
—
About Nexgel Inc
NEXGEL, Inc. manufactures aqueous, electron beam crosslinked, high water content hydrogels and polymeric gels. The company is headquartered in Langhorne, Pennsylvania.
Fundamentals
| Revenue (TTM) | $12.07M |
| Gross Profit (TTM) | $4.23M |
| EBITDA | $-4.25M |
| Operating Margin | -68.00% |
| Return on Equity | -115.10% |
| Return on Assets | -18.70% |
| Revenue/Share (TTM) | $1.46 |
| Book Value | $0.51 |
| Price-to-Book | 0.67 |
| Price-to-Sales (TTM) | 0.26 |
| EV/Revenue | 0.852 |
| EV/EBITDA | -0.85 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 27.80% |
| Shares Outstanding | $9.75M |
| Float | $7.69M |
| % Insiders | 14.02% |
| % Institutions | 13.67% |
Historical Volatility
HV 10-Day
185.13%
HV 20-Day
138.48%
HV 30-Day
122.96%
HV 60-Day
109.54%
HV Rank
87.3%
Volatility is currently expanding
Latest News
NEXGEL To Report First Quarter 2026 Financial Results on May 15th
Management Will Host a Conference Call at 12:00 P.M. ET on the Same Day LANGHORNE, Pa.
GlobeNewsWire5/12/2026Neutral
NEXGEL, Inc. (NXGL) Q4 2025 Earnings Call Transcript
NEXGEL, Inc. (NXGL) Q4 2025 Earnings Call Transcript
Seeking Alpha4/21/2026Neutral
NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET
LANGHORNE, Pa., April 17, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it is moving up its shareholder update conference call from Thursday, April 23rd to Tuesday, April 21st, 2026, at 4:30 P.M. ET.
GlobeNewsWire4/17/2026Neutral
NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction
LANGHORNE, Pa., April 15, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the rescheduling of its shareholder update conference call to April 23, 2026, at 4:30 P.M. ET.
GlobeNewsWire4/15/2026Neutral
NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction
LANGHORNE, Pa., April 08, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the rescheduling of its shareholder update conference call to April 15, 2026, at 4:30 P.M. ET.
GlobeNewsWire4/8/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NXGL and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/7/2026